OBJECTIVE: To identify biological and clinical predictors of acute kidney injury in subjects with acute lung injury. DESIGN: Secondary data analysis from a multicenter, randomized clinical trial. SETTING:Intensive care units in ten university medical centers. PATIENTS: A total of 876 patients enrolled in the first National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Clinical Network trial. INTERVENTIONS: Study subjects were randomized to receive a low tidal volume ventilation strategy and pharmacologic therapy with ketoconazole or lisofylline in a factorial design. MEASUREMENTS AND MAIN RESULTS: We tested the association of baseline levels of interleukin-6, interleukin-8, interleukin-10, von Willebrand factor, tumor necrosis factor-[alpha], type I and II soluble tumor necrosis factor receptors (sTNFR-I and -II), protein C, plasminogen activator inhibitor-1 (PAI-1), surfactant protein-A, surfactant protein-D, and intracellular adhesion molecule-1 with subsequent acute kidney injury. Of 876 study participants who did not have end-stage renal disease, 209 (24%) developed acute kidney injury, defined as a rise in serum creatinine of >50% from baseline over the first four study days. The 180-day mortality rate for subjects with acute kidney injury was 58%, compared with 28% in those without acute kidney injury (p < .001). Interleukin-6, sTNFR-I, sTNFR-II, and PAI-1 levels were independently associated with acute kidney injury after adjustment for demographics, interventions, and severity of illness. A combination of clinical and biological predictors had the best area under the receiver operating characteristic curve, and the contribution of sTNFR-I and PAI-1 to this model was highly significant (p = .0003). CONCLUSIONS: Elevations in PAI-1, interleukin-6, and the sTNFRs in subjects with acute kidney injury suggest that disordered coagulation, inflammation, and neutrophil-endothelial interactions play important roles in the pathogenesis of acute kidney injury. The combination of these biological and clinical risk factors may have important and additive value in predictive models for acute kidney injury.
RCT Entities:
OBJECTIVE: To identify biological and clinical predictors of acute kidney injury in subjects with acute lung injury. DESIGN: Secondary data analysis from a multicenter, randomized clinical trial. SETTING: Intensive care units in ten university medical centers. PATIENTS: A total of 876 patients enrolled in the first National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Clinical Network trial. INTERVENTIONS: Study subjects were randomized to receive a low tidal volume ventilation strategy and pharmacologic therapy with ketoconazole or lisofylline in a factorial design. MEASUREMENTS AND MAIN RESULTS: We tested the association of baseline levels of interleukin-6, interleukin-8, interleukin-10, von Willebrand factor, tumor necrosis factor-[alpha], type I and II soluble tumor necrosis factor receptors (sTNFR-I and -II), protein C, plasminogen activator inhibitor-1 (PAI-1), surfactant protein-A, surfactant protein-D, and intracellular adhesion molecule-1 with subsequent acute kidney injury. Of 876 study participants who did not have end-stage renal disease, 209 (24%) developed acute kidney injury, defined as a rise in serum creatinine of >50% from baseline over the first four study days. The 180-day mortality rate for subjects with acute kidney injury was 58%, compared with 28% in those without acute kidney injury (p < .001). Interleukin-6, sTNFR-I, sTNFR-II, and PAI-1 levels were independently associated with acute kidney injury after adjustment for demographics, interventions, and severity of illness. A combination of clinical and biological predictors had the best area under the receiver operating characteristic curve, and the contribution of sTNFR-I and PAI-1 to this model was highly significant (p = .0003). CONCLUSIONS: Elevations in PAI-1, interleukin-6, and the sTNFRs in subjects with acute kidney injury suggest that disordered coagulation, inflammation, and neutrophil-endothelial interactions play important roles in the pathogenesis of acute kidney injury. The combination of these biological and clinical risk factors may have important and additive value in predictive models for acute kidney injury.
Authors: Polly E Parsons; Michael A Matthay; Lorraine B Ware; Mark D Eisner Journal: Am J Physiol Lung Cell Mol Physiol Date: 2004-10-29 Impact factor: 5.464
Authors: Glenn M Chertow; Elisabeth Burdick; Melissa Honour; Joseph V Bonventre; David W Bates Journal: J Am Soc Nephrol Date: 2005-09-21 Impact factor: 10.121
Authors: Ivan W Cheng; Lorraine B Ware; Kelly E Greene; Thomas J Nuckton; Mark D Eisner; Michael A Matthay Journal: Crit Care Med Date: 2003-01 Impact factor: 7.598
Authors: Chirag R Parikh; Alkesh Jani; Vyacheslav Y Melnikov; Sarah Faubel; Charles L Edelstein Journal: Am J Kidney Dis Date: 2004-03 Impact factor: 8.860
Authors: A Ahlström; M Hynninen; M Tallgren; P Kuusela; M Valtonen; R Orko; S Siitonen; O Takkunen; V Pettilä Journal: Clin Nephrol Date: 2004-02 Impact factor: 0.975
Authors: Michael A Matthay; B Taylor Thompson; Elizabeth J Read; David H McKenna; Kathleen D Liu; Carolyn S Calfee; Jae Woo Lee Journal: Chest Date: 2010-10 Impact factor: 9.410
Authors: William R Zhang; Amit X Garg; Steven G Coca; Philip J Devereaux; John Eikelboom; Peter Kavsak; Eric McArthur; Heather Thiessen-Philbrook; Colleen Shortt; Michael Shlipak; Richard Whitlock; Chirag R Parikh Journal: J Am Soc Nephrol Date: 2015-04-08 Impact factor: 10.121
Authors: Jason H Greenberg; Richard Whitlock; William R Zhang; Heather R Thiessen-Philbrook; Michael Zappitelli; Prasad Devarajan; John Eikelboom; Peter A Kavsak; P J Devereaux; Colleen Shortt; Amit X Garg; Chirag R Parikh Journal: Pediatr Nephrol Date: 2015-04-15 Impact factor: 3.714
Authors: Michael G S Shashaty; Nuala J Meyer; A Russell Localio; Robert Gallop; Scarlett L Bellamy; Daniel N Holena; Paul N Lanken; Sandra Kaplan; Dilek Yarar; Steven M Kawut; Harold I Feldman; Jason D Christie Journal: J Crit Care Date: 2012-05-15 Impact factor: 3.425
Authors: Paulette D Chandler; Jamil B Scott; Bettina F Drake; Kimmie Ng; Joann E Manson; Nader Rifai; Andrew T Chan; Gary G Bennett; Bruce W Hollis; Edward L Giovannucci; Karen M Emmons; Charles S Fuchs Journal: Cancer Prev Res (Phila) Date: 2013-12-10
Authors: Michael G S Shashaty; Esra Kalkan; Scarlett L Bellamy; John P Reilly; Daniel N Holena; Kathleen Cummins; Paul N Lanken; Harold I Feldman; Muredach P Reilly; Jayaram K Udupa; Jason D Christie Journal: Crit Care Med Date: 2014-07 Impact factor: 7.598
Authors: Kevin W Lobdell; Devin M Parker; Donald S Likosky; Michael Rezaee; Moritz Wyler von Ballmoos; Shama S Alam; Sherry Owens; Heather Thiessen-Philbrook; Todd MacKenzie; Jeremiah R Brown Journal: J Thorac Cardiovasc Surg Date: 2018-04-11 Impact factor: 5.209
Authors: Kathleen D Liu; Christopher Altmann; Gerard Smits; Catherine D Krawczeski; Charles L Edelstein; Prasad Devarajan; Sarah Faubel Journal: Crit Care Date: 2009-07-01 Impact factor: 9.097